Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
1,391,267
-
Shares change
-
-559,813
-
Total reported value, excl. options
-
$92,698,931
-
Value change
-
-$36,792,997
-
Put/Call ratio
-
345%
-
Number of buys
-
14
-
Number of sells
-
-22
-
Price
-
$66.48
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q4 2020
62 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q4 2020.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,391,267 shares
.
Largest 10 shareholders include Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) (344,000 shares), Clough Capital Partners L P (330,400 shares), GOLDMAN SACHS GROUP INC (220,127 shares), Brinker Capital Investments, LLC (110,000 shares), 20/20 Capital Management, Inc. (97,686 shares), Orion Portfolio Solutions, LLC (64,100 shares), MORGAN STANLEY (35,715 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (33,231 shares), BANK OF AMERICA CORP /DE/ (29,937 shares), and ROYAL BANK OF CANADA (24,565 shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.